These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26225729)

  • 41. The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis.
    Buckley ML; Ramji DP
    Biochim Biophys Acta; 2015 Jul; 1852(7):1498-510. PubMed ID: 25887161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue.
    Vyth-Dreese FA; Dellemijn TA; Majoor D; de Jong D
    Eur J Immunol; 1995 Nov; 25(11):3023-9. PubMed ID: 7489738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.
    Leifeld L; Trautwein C; Dumoulin FL; Manns MP; Sauerbruch T; Spengler U
    Am J Pathol; 1999 Jun; 154(6):1711-20. PubMed ID: 10362796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Defects in regulation of local immune responses resulting in atherosclerosis.
    Ferencík M; Stvrtinová V; Hulín I
    Clin Dev Immunol; 2005 Sep; 12(3):225-34. PubMed ID: 16295529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
    Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
    Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leukotrienes as a molecular link between obstructive sleep apnoea and atherosclerosis.
    Stanke-Labesque F; Pépin JL; Gautier-Veyret E; Lévy P; Bäck M
    Cardiovasc Res; 2014 Feb; 101(2):187-93. PubMed ID: 24204032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Innate sensors of pathogen and stress: linking inflammation to obesity.
    Jin C; Flavell RA
    J Allergy Clin Immunol; 2013 Aug; 132(2):287-94. PubMed ID: 23905917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles.
    Taleb S; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):258-64. PubMed ID: 25234818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Innate immunity, macrophage activation, and atherosclerosis.
    Yan ZQ; Hansson GK
    Immunol Rev; 2007 Oct; 219():187-203. PubMed ID: 17850490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The CD40/CD40L system: a new therapeutic target for disease.
    Zhang B; Wu T; Chen M; Zhou Y; Yi D; Guo R
    Immunol Lett; 2013 Jun; 153(1-2):58-61. PubMed ID: 23892087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Co-stimulation and plaque-antigen-specific T-cell responses in atherosclerosis.
    Buono C; Lichtman AH
    Trends Cardiovasc Med; 2004 May; 14(4):166-72. PubMed ID: 15177268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity.
    Joffre O; Nolte MA; Spörri R; Reis e Sousa C
    Immunol Rev; 2009 Jan; 227(1):234-47. PubMed ID: 19120488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The role of T-regulatory cells in the pathogenesis of immunological disturbances accompanying obesity and atherosclerosis].
    Luczyński W; Bossowski A; Głowińska-Olszewska B; Kos J; Stasiak-Barmuta A
    Postepy Hig Med Dosw (Online); 2010 Mar; 64():156-60. PubMed ID: 20354263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early events in Sjögren's Syndrome pathogenesis: the importance of innate immunity in disease initiation.
    Kramer JM
    Cytokine; 2014 Jun; 67(2):92-101. PubMed ID: 24656928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombosis and obesity: cellular bases.
    Lorenzet R; Napoleone E; Cutrone A; Donati MB
    Thromb Res; 2012 Mar; 129(3):285-9. PubMed ID: 22078462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Metabolic or immunometabolic syndrome?].
    Wysocki J; Skoczyński S; Strózik A; Hochuł B; Zyguła M
    Wiad Lek; 2005; 58(1-2):124-7. PubMed ID: 15991565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccination strategies in atherosclerosis.
    de Jager SC; Kuiper J
    Thromb Haemost; 2011 Nov; 106(5):796-803. PubMed ID: 22012002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammation, cytokines and insulin resistance: a clinical perspective.
    Wieser V; Moschen AR; Tilg H
    Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):119-25. PubMed ID: 23307037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells.
    Park W; Weyand CM; Schmidt D; Goronzy JJ
    Eur J Immunol; 1997 May; 27(5):1082-90. PubMed ID: 9174596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.